Literature DB >> 32284364

Coxiella burnetii Requires Host Eukaryotic Initiation Factor 2α Activity for Efficient Intracellular Replication.

Katelynn R Brann1, Marissa S Fullerton1, Daniel E Voth2.   

Abstract

Coxiella burnetii is the causative agent of human Q fever, eliciting symptoms that range from acute fever and fatigue to chronic fatal endocarditis. C. burnetii is a Gram-negative intracellular bacterium that replicates within an acidic lysosome-like parasitophorous vacuole (PV) in human macrophages. During intracellular growth, C. burnetii delivers bacterial proteins directly into the host cytoplasm using a Dot/Icm type IV secretion system (T4SS). Multiple T4SS effectors localize to and/or disrupt the endoplasmic reticulum (ER) and secretory transport, but their role in infection is unknown. During microbial infection, unfolded nascent proteins may exceed the folding capacity of the ER, activating the unfolded protein response (UPR) and restoring the ER to its normal physiological state. A subset of intracellular pathogens manipulates the UPR to promote survival and replication in host cells. In this study, we investigated the impact of C. burnetii infection on activation of the three arms of the UPR. An inhibitor of the UPR antagonized PV expansion in macrophages, indicating this process is needed for bacterial replication niche formation. Protein kinase RNA-like ER kinase (PERK) signaling was activated during infection, leading to increased levels of phosphorylated eukaryotic initiation factor α, which was required for C. burnetii growth. Increased production and nuclear translocation of the transcription factor ATF4 also occurred, which normally drives expression of the proapoptotic C/EBP homologous protein (CHOP). CHOP protein production increased during infection; however, C. burnetii actively prevented CHOP nuclear translocation and downstream apoptosis in a T4SS-dependent manner. The results collectively demonstrate interplay between C. burnetii and specific components of the eIF2α signaling cascade to parasitize human macrophages.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Coxiella burnetiizzm321990; apoptosis; eIF2α; intracellular; macrophage; unfolded protein response

Year:  2020        PMID: 32284364      PMCID: PMC7309603          DOI: 10.1128/IAI.00096-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

Review 1.  Cell death induced by endoplasmic reticulum stress.

Authors:  Raffaella Iurlaro; Cristina Muñoz-Pinedo
Journal:  FEBS J       Date:  2015-12-19       Impact factor: 5.542

Review 2.  Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii.

Authors:  Daniel E Voth; Robert A Heinzen
Journal:  Cell Microbiol       Date:  2007-04       Impact factor: 3.715

3.  Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages.

Authors:  Daniel E Voth; Dale Howe; Robert A Heinzen
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

Review 4.  Signal integration via PKR.

Authors:  B R Williams
Journal:  Sci STKE       Date:  2001-07-03

5.  Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections.

Authors:  Robert E Brennan; Kasi Russell; Guoquan Zhang; James E Samuel
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Sustained activation of Akt and Erk1/2 is required for Coxiella burnetii antiapoptotic activity.

Authors:  Daniel E Voth; Robert A Heinzen
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

7.  Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.

Authors:  Paul A Beare; Stacey D Gilk; Charles L Larson; Joshua Hill; Christopher M Stead; Anders Omsland; Diane C Cockrell; Dale Howe; Daniel E Voth; Robert A Heinzen
Journal:  mBio       Date:  2011-09-01       Impact factor: 7.867

8.  The Coxiella burnetii Dot/Icm system delivers a unique repertoire of type IV effectors into host cells and is required for intracellular replication.

Authors:  Kimberly L Carey; Hayley J Newton; Anja Lührmann; Craig R Roy
Journal:  PLoS Pathog       Date:  2011-05-26       Impact factor: 6.823

9.  Yip1A, a novel host factor for the activation of the IRE1 pathway of the unfolded protein response during Brucella infection.

Authors:  Yuki Taguchi; Koichi Imaoka; Michiyo Kataoka; Akihiko Uda; Daiki Nakatsu; Sakuya Horii-Okazaki; Rina Kunishige; Fumi Kano; Masayuki Murata
Journal:  PLoS Pathog       Date:  2015-03-05       Impact factor: 6.823

10.  The host-encoded Heme Regulated Inhibitor (HRI) facilitates virulence-associated activities of bacterial pathogens.

Authors:  Niraj Shrestha; Justin Boucher; Wael Bahnan; Emily S Clark; Roland Rosqvist; Kenneth A Fields; Wasif N Khan; Kurt Schesser
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

View more
  5 in total

1.  To die or not to die: Programmed cell death responses and their interactions with Coxiella burnetii infection.

Authors:  Chelsea A Osbron; Alan G Goodman
Journal:  Mol Microbiol       Date:  2022-02-02       Impact factor: 3.979

Review 2.  Arthropods Under Pressure: Stress Responses and Immunity at the Pathogen-Vector Interface.

Authors:  Kristin L Rosche; Lindsay C Sidak-Loftis; Joanna Hurtado; Elizabeth A Fisk; Dana K Shaw
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 8.786

Review 3.  Undercover Agents of Infection: The Stealth Strategies of T4SS-Equipped Bacterial Pathogens.

Authors:  Arthur Bienvenu; Eric Martinez; Matteo Bonazzi
Journal:  Toxins (Basel)       Date:  2021-10-09       Impact factor: 4.546

Review 4.  Protein Kinase R in Bacterial Infections: Friend or Foe?

Authors:  Robin Smyth; Jim Sun
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

5.  Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.

Authors:  Marissa S Fullerton; Punsiri M Colonne; Amanda L Dragan; Katelynn R Brann; Richard C Kurten; Daniel E Voth
Journal:  mSphere       Date:  2021-07-07       Impact factor: 4.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.